These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 16823844)
1. COX-2 upregulation in thymomas and thymic carcinomas. Rieker RJ; Joos S; Mechtersheimer G; Blaeker H; Schnabel PA; Morresi-Hauf A; Hecker E; Thomas M; Dienemann H; Schirmacher P; Kern MA Int J Cancer; 2006 Nov; 119(9):2063-70. PubMed ID: 16823844 [TBL] [Abstract][Full Text] [Related]
2. Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas. Meister M; Schirmacher P; Dienemann H; Mechtersheimer G; Schnabel PA; Kern MA; Herpel E; Xu EC; Muley T; Thomas M; Rieker RJ Cancer Lett; 2007 Apr; 248(2):186-91. PubMed ID: 16919868 [TBL] [Abstract][Full Text] [Related]
3. Mutational status of EGFR and KIT in thymoma and thymic carcinoma. Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor expression in invasive thymoma. Henley JD; Koukoulis GK; Loehrer PJ J Cancer Res Clin Oncol; 2002 Mar; 128(3):167-70. PubMed ID: 11935304 [TBL] [Abstract][Full Text] [Related]
5. Expression of proteasome subunit β5t in thymic epithelial tumors. Yamada Y; Tomaru U; Ishizu A; Kiuchi T; Marukawa K; Matsuno Y; Kasahara M Am J Surg Pathol; 2011 Sep; 35(9):1296-304. PubMed ID: 21836487 [TBL] [Abstract][Full Text] [Related]
6. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors. Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968 [TBL] [Abstract][Full Text] [Related]
7. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems. Walts AE; Hiroshima K; Marchevsky AM Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Girard N; Shen R; Guo T; Zakowski MF; Heguy A; Riely GJ; Huang J; Lau C; Lash AE; Ladanyi M; Viale A; Antonescu CR; Travis WD; Rusch VW; Kris MG; Pao W Clin Cancer Res; 2009 Nov; 15(22):6790-9. PubMed ID: 19861435 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma. Katsuya Y; Fujita Y; Horinouchi H; Ohe Y; Watanabe S; Tsuta K Lung Cancer; 2015 May; 88(2):154-9. PubMed ID: 25799277 [TBL] [Abstract][Full Text] [Related]
10. Messenger RNA and protein expression of thymidylate synthase and DNA repair genes in thymic tumors. Monica V; Familiari U; Chiusa L; Rossi G; Novero D; Busso S; Ruffini E; Ardissone F; Scagliotti GV; Papotti M Lung Cancer; 2013 Mar; 79(3):228-35. PubMed ID: 23276504 [TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase receptor expression in thymomas. Henley JD; Cummings OW; Loehrer PJ J Cancer Res Clin Oncol; 2004 Apr; 130(4):222-4. PubMed ID: 14762710 [TBL] [Abstract][Full Text] [Related]
12. Steroid receptor expression in thymomas and thymic carcinomas. Mimae T; Tsuta K; Takahashi F; Yoshida A; Kondo T; Murakami Y; Okada M; Takeuchi M; Asamura H; Tsuda H Cancer; 2011 Oct; 117(19):4396-405. PubMed ID: 21437890 [TBL] [Abstract][Full Text] [Related]
13. PD-L1, PD-1, CD4, and CD8 expression in neoplastic and nonneoplastic thymus. Marchevsky AM; Walts AE Hum Pathol; 2017 Feb; 60():16-23. PubMed ID: 27746267 [TBL] [Abstract][Full Text] [Related]
14. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets. Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328 [TBL] [Abstract][Full Text] [Related]
16. Thymic tumors: relevant molecular data in the clinic. Girard N J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S291-5. PubMed ID: 20859122 [TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation: common in thymic carcinomas, rare in thymomas. Suzuki M; Chen H; Shigematsu H; Ando S; Iida T; Nakajima T; Fujisawa T; Kimura H Oncol Rep; 2005 Dec; 14(6):1621-4. PubMed ID: 16273266 [TBL] [Abstract][Full Text] [Related]
18. [Thymoma and thymic carcinoma--review of literature and clinical characteristics based on the Polish Paediatric Solid Tumours Study Group experience]. Stachowicz-Stencel T; Bień E; Balcerska A; Godziński J; Madziara W; Perek-Polnik M; Peregud-Pogorzelski J; Pietras W; Pobudejska A; Kurylak A; Mańkowski P Med Wieku Rozwoj; 2007; 11(3 Pt 2):313-8. PubMed ID: 18663273 [TBL] [Abstract][Full Text] [Related]
19. Expression of neurotrophin receptors in surgically resected thymic epithelial tumors. Kim DJ; Yang WI; Kim SH; Park IK; Chung KY Eur J Cardiothorac Surg; 2005 Oct; 28(4):611-6. PubMed ID: 16125946 [TBL] [Abstract][Full Text] [Related]
20. [Therapy-relevant mutations of receptor tyrosine kinases in malignant thymomas and thymic carcinomas: a therapeutic perspective]. Ströbel P; Knop S; Einsele H; Müller-Hermelink HK; Marx A Verh Dtsch Ges Pathol; 2007; 91():177-86. PubMed ID: 18314613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]